{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:33:07Z","timestamp":1791462787168,"version":"4.3.4"},"reference-count":121,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Ovarian clear cell (OCCC) and endometrioid (EnOC) carcinomas are often subsumed under the umbrella term \u201cendometriosis-associated ovarian cancer\u201d (EAOC), since they frequently arise from ectopic endometrium settled in the ovaries. The phosphatidylinositol 3-kinase (PI3K)\/protein kinase B (AKT)\/mammalian target of rapamycin (mTOR) pathway is known to be aberrantly activated both in endometriosis and EAOC; however, its role in the progression of endometriosis to ovarian cancer remains unclear. In fact, cancer-associated alterations in the mTOR pathway may be found in normal uterine epithelium, likely acting as a first step towards ovarian cancer, through the intermediary stage of endometriosis. This review aims to summarize the current knowledge regarding mTOR signaling dysregulation in the uterine endometrium, endometriosis, and EAOC while focusing on the interconnections between the PI3K\/AKT\/mTOR pathway and other signaling molecules that give rise to synergistic molecular mechanisms triggering ovarian cancer development in the presence of endometriosis.<\/jats:p>","DOI":"10.3390\/biom13081253","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T09:57:02Z","timestamp":1692179822000},"page":"1253","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Endometriosis-Associated Ovarian Carcinomas: How PI3K\/AKT\/mTOR Pathway Affects Their Pathogenesis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9511-6393","authenticated-orcid":false,"given":"Tatiana S.","family":"Driva","sequence":"first","affiliation":[{"name":"First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-3400","authenticated-orcid":false,"given":"Christoph","family":"Schatz","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria"},{"name":"Diagnostic & Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, 8010 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-019-05358-8","article-title":"Endometriosis and Risk of Ovarian Cancer: What Do We Know?","volume":"301","author":"Ghezzi","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/GRF.0000000000000320","article-title":"Endometriosis-Associated Ovarian Cancers","volume":"60","author":"Anglesio","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: Pathogenesis and Treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wang, C., Liang, Z., Liu, X., Zhang, Q., and Li, S. (2016). The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses. Int. J. Environ. Res. Public. Health, 13.","DOI":"10.3390\/ijerph13111138"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between Endometriosis and Risk of Histological Subtypes of Ovarian Cancer: A Pooled Analysis of Case\u2013Control Studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_7","first-page":"47","article-title":"Differential Expression of MTOR Components in Endometriosis and Ovarian Cancer: Effects of Rapalogues and Dual Kinase Inhibitors on MTORC1 and MTORC2 Stoichiometry","volume":"43","author":"Kumar","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"MTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ceb.2011.09.003","article-title":"MTOR Signaling in Disease","volume":"23","author":"Dazert","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","article-title":"Role of the PI3K\/AKT\/MTOR Signaling Pathway in Ovarian Cancer: Biological and Therapeutic Significance","volume":"59","author":"Ediriweera","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Driva, T.S., Schatz, C., Sobo\u010dan, M., and Haybaeck, J. (2022). The Role of MTOR and EIF Signaling in Benign Endometrial Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073416"},{"key":"ref_12","first-page":"115","article-title":"TOR Action in Mammalian Cells and in Caenorhabditis Elegans","volume":"279","author":"Long","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1038\/jid.2015.252","article-title":"Dual MTOR Inhibition Is Required to Prevent TGF-&beta;-Mediated Fibrosis: Implications for Scleroderma","volume":"135","author":"Mitra","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","article-title":"Two TOR Complexes, Only One of Which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control","volume":"10","author":"Loewith","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/msb.2010.108","article-title":"A Comprehensive Map of the MTOR Signaling Network","volume":"6","author":"Caron","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The Phosphoinositide 3-Kinase Pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 Complex: A Molecular Switchboard Controlling Cell Growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrm2672","article-title":"Molecular Mechanisms of MTOR-Mediated Translational Control","volume":"10","author":"Ma","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15461","DOI":"10.1074\/jbc.C200665200","article-title":"The Mammalian Target of Rapamycin (MTOR) Partner, Raptor, Binds the MTOR Substrates P70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif","volume":"278","author":"Nojima","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_20","first-page":"1992","article-title":"ULK-Atg13-FIP200 Complexes Mediate MTOR Signaling to the Autophagy Machinery","volume":"20","author":"Ro","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR Complex 2 Controls the Actin Cytoskeleton and Is Rapamycin Insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ncb2507","article-title":"PRR5L Degradation Promotes MTORC2-Mediated PKC-\u03b4 Phosphorylation and Cell Migration Downstream of G\u03b1 12","volume":"14","author":"Gan","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-Induced Insulin Resistance Is Mediated by MTORC2 Loss and Uncoupled from Longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3389\/fendo.2019.00692","article-title":"Role of MTOR Signaling in Female Reproduction","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/15548627.2020.1752548","article-title":"Autophagy in the Physiological Endometrium and Cancer","volume":"17","author":"Eritja","year":"2021","journal-title":"Autophagy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/molehr\/gat091","article-title":"Differential Induction of Autophagy by MTOR Is Associated with Abnormal Apoptosis in Ovarian Endometriotic Cysts","volume":"20","author":"Choi","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1095\/biolreprod.111.096206","article-title":"The Role of Autophagy in Human Endometrium","volume":"86","author":"Choi","year":"2012","journal-title":"Biol. Reprod."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/er.2014-1045","article-title":"Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure","volume":"35","author":"Gellersen","year":"2014","journal-title":"Endocr. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/humrep\/dew191","article-title":"Nm23 Regulates Decidualization through the PI3K-Akt-MTOR Signaling Pathways in Mice and Humans","volume":"31","author":"Zhang","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","article-title":"Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium","volume":"24","author":"Suda","year":"2018","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.5314","article-title":"Oncogenic Mutations in Histologically Normal Endometrium: The New Normal?","volume":"249","author":"Lac","year":"2019","journal-title":"J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41586-020-2214-z","article-title":"The Mutational Landscape of Normal Human Endometrial Epithelium","volume":"580","author":"Moore","year":"2020","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1111\/cas.14571","article-title":"Cancer-Associated Mutations in Normal Human Endometrium: Surprise or Expected?","volume":"111","author":"Kyo","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/humrep\/dey332","article-title":"Iatrogenic Endometriosis Harbors Somatic Cancer-Driver Mutations","volume":"34","author":"Lac","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Yachida, N., Yoshihara, K., Yamaguchi, M., Suda, K., Tamura, R., and Enomoto, T. (2021). How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development. Cancers, 13.","DOI":"10.3390\/cancers13061439"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1210\/jc.2011-1527","article-title":"Increased Activation of the PI3K\/AKT Pathway Compromises Decidualization of Stromal Cells from Endometriosis","volume":"97","author":"Yin","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/09513590.2011.583955","article-title":"PI3K-Akt-MTOR and MAPK Signaling Pathways in Polycystic Ovarian Syndrome, Uterine Leiomyomas and Endometriosis: An Update","volume":"28","author":"Makker","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.rbmo.2009.10.001","article-title":"Differential Regulation of Akt Phosphorylation in Endometriosis","volume":"19","author":"Cinar","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/humrep\/dep175","article-title":"Expression of Selected Tumor Suppressor and Oncogenes in Endometrium of Women with Endometriosis","volume":"24","author":"Laudanski","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7827-6-59","article-title":"Serial Analysis of Gene Expression Reveals Differential Expression between Endometriosis and Normal Endometrium. Possible Roles for AXL and SHC1 in the Pathogenesis of Endometriosis","volume":"6","author":"Honda","year":"2008","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/molehr\/gap069","article-title":"Endometriotic Stromal Cells Lose the Ability to Regulate Cell-Survival Signaling in Endometrial Epithelial Cells In Vitro","volume":"15","author":"Zhang","year":"2009","journal-title":"Mol. Hum. Reprod."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/09513590.2019.1680627","article-title":"PI3K\/AKT Pathway Is Altered in the Endometriosis Patient\u2019s Endometrium and Presents Differences According to Severity Stage","volume":"36","author":"Madanes","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1210\/en.2013-1951","article-title":"Activated AKT Pathway Promotes Establishment of Endometriosis","volume":"155","author":"Kim","year":"2014","journal-title":"Endocrinology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-Associated Mutations in Endometriosis without Cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tem.2018.05.006","article-title":"Progesterone Resistance in Endometriosis: An Acquired Property?","volume":"29","author":"McKinnon","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Marquardt, R.M., Kim, T.H., Shin, J.H., and Jeong, J.W. (2019). Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153822"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"117190","DOI":"10.1016\/j.lfs.2019.117190","article-title":"MiR-92a Promotes Progesterone Resistance in Endometriosis through PTEN\/AKT Pathway","volume":"242","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"ref_48","first-page":"6136","article-title":"Effect of miR-194-5p regulating STAT1\/mTOR signaling pathway on the biological characteristics of ectopic endometrial cells from mice","volume":"2","author":"Zhao","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1080\/21655979.2021.1933679","article-title":"MicroRNA MiR-106a-5p Targets Forkhead Box Transcription Factor FOXC1 to Suppress the Cell Proliferation, Migration, and Invasion of Ectopic Endometrial Stromal Cells via the PI3K\/Akt\/MTOR Signaling Pathway","volume":"12","author":"Zhou","year":"2021","journal-title":"Bioengineered"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.fertnstert.2015.05.020","article-title":"Dienogest Enhances Autophagy Induction in Endometriotic Cells by Impairing Activation of AKT, ERK1\/2, and MTOR","volume":"104","author":"Choi","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ajpath.2011.04.020","article-title":"The MTOR\/AKT Inhibitor Temsirolimus Prevents Deep Infiltrating Endometriosis in Mice","volume":"179","author":"Leconte","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3892\/etm.2016.3280","article-title":"Effect of Rapamycin on Endometriosis in Mice","volume":"12","author":"Ren","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Cao, Y., Ye, Q., Zhuang, M., Xie, S., Zhong, R., Cui, J., Zhou, J., Zhu, Y., Zhang, T., and Cao, L. (2017). Ginsenoside Rg3 Inhibits Angiogenesis in a Rat Model of Endometriosis through the VEGFR-2-Mediated PI3K\/Akt\/MTOR Signaling Pathway. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186520"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2016.07.095","article-title":"Endometriosis and Risks for Ovarian, Endometrial and Breast Cancers: A Nationwide Cohort Study","volume":"143","author":"Mogensen","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.ajpath.2017.06.012","article-title":"Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks","volume":"187","author":"Murakami","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.4516","article-title":"Multifocal Endometriotic Lesions Associated with Cancer Are Clonal and Carry a High Mutation Burden","volume":"236","author":"Anglesio","year":"2015","journal-title":"J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.3390\/ijms14035367","article-title":"Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis","volume":"14","author":"Worley","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13048-021-00876-z","article-title":"Identification and Clinical Significance of Somatic Oncogenic Mutations in Epithelial Ovarian Cancer","volume":"14","author":"Watanabe","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2019.07.012","article-title":"Molecular Profiling and Molecular Classification of Endometrioid Ovarian Carcinomas","volume":"154","author":"Cybulska","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1038\/s41467-020-18819-5","article-title":"Molecular Stratification of Endometrioid Ovarian Carcinoma Predicts Clinical Outcome","volume":"11","author":"Hollis","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2020.02.011","article-title":"An Integrated Molecular Profile of Endometrioid Ovarian Cancer","volume":"157","author":"Pierson","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"18824","DOI":"10.3390\/ijms140918824","article-title":"ARID1A Mutations and PI3K\/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas","volume":"14","author":"Samartzis","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_63","first-page":"49","article-title":"Diagnostic Significance and Prognostic Role of the ARID1A Gene in Cancer Outcomes (Review)","volume":"2","author":"Pavlidou","year":"2020","journal-title":"World Acad. Sci. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/cbt.28411","article-title":"The Emerging Roles of ARID1A in Tumor Suppression","volume":"15","author":"Wu","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.21037\/atm-20-3022a","article-title":"Endometriosis-Associated Ovarian Carcinomas: Insights into Pathogenesis, Diagnostics, and Therapeutic Targets\u2014A Narrative Review","volume":"8","author":"Samartzis","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IGC.0000000000000698","article-title":"BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer","volume":"26","author":"Stamp","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2018.03.001","article-title":"The Presence of KRAS, PPP2R1A and ARID1A Mutations in 101 Chinese Samples with Ovarian Endometriosis","volume":"809","author":"Zou","year":"2018","journal-title":"Mutat. Res.-Fundam. Mol. Mech. Mutagen."},{"key":"ref_68","first-page":"4509","article-title":"Reactive Oxygen Species Downregulate ARID1A Expression via Its Promoter Methylation during the Pathogenesis of Endometriosis","volume":"21","author":"Xie","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_69","first-page":"642","article-title":"Loss of ARID1A\/BAF250a expression in ovarian endometriosis and clear cell carcinoma","volume":"5","author":"Xiao","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A Protein Expression Occurs as an Early Event in Ovarian Clear-Cell Carcinoma Development and Frequently Coexists with PIK3CA Mutations","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ejca.2015.05.011","article-title":"Molecular Changes in Endometriosis-Associated Ovarian Clear Cell Carcinoma","volume":"51","author":"Worley","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/IGC.0b013e31826b5dcc","article-title":"Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression from Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma","volume":"22","author":"Ayhan","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"14260","DOI":"10.1038\/s41598-020-71273-7","article-title":"ARID1A Protein Expression Is Retained in Ovarian Endometriosis with ARID1A Loss-of-Function Mutations: Implication for the Two-Hit Hypothesis","volume":"10","author":"Yachida","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/ncomms7118","article-title":"Coexistent ARID1A-PIK3CA Mutations Promote Ovarian Clear-Cell Tumorigenesis through pro-Tumorigenic Inflammatory Cytokine Signalling","volume":"6","author":"Chandler","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2013.216","article-title":"Loss of ARID1A Expression and Its Relationship with PI3K-Akt Pathway Alterations and ZNF217 Amplification in Ovarian Clear Cell Carcinoma","volume":"27","author":"Huang","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Wiegand, K.C., Hennessy, B.T., Leung, S., Wang, Y., Ju, Z., McGahren, M., Kalloger, S.E., Finlayson, S., Stemke-Hale, K., and Lu, Y. (2014). A Functional Proteogenomic Analysis of Endometrioid and Clear Cell Carcinomas Using Reverse Phase Protein Array and Mutation Analysis: Protein Expression Is Histotype-Specific and Loss of ARID1A\/BAF250a Is Associated with AKT Phosphorylation. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-120"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijgo.2015.02.021","article-title":"The ARID1A Pathway in Ovarian Clear Cell and Endometrioid Carcinoma, Contiguous Endometriosis, and Benign Endometriosis","volume":"130","author":"Chene","year":"2015","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1038\/onc.2010.289","article-title":"ZNF217, a Candidate Breast Cancer Oncogene Amplified at 20q13, Regulates Expression of the ErbB3 Receptor Tyrosine Kinase in Breast Cancer Cells","volume":"29","author":"Krig","year":"2010","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2013.107","article-title":"Ovarian and Endometrial Endometrioid Carcinomas Have Distinct CTNNB1 and PTEN Mutation Profiles","volume":"27","author":"McConechy","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22507","article-title":"Identification of Somatic Genetic Alterations in Ovarian Clear Cell Carcinoma with next Generation Sequencing","volume":"57","author":"Shibuya","year":"2018","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.18632\/oncotarget.24546","article-title":"Affinity-Purified DNA-Based Mutation Profiles of Endometriosis-Related Ovarian Neoplasms in Japanese Patients","volume":"9","author":"Ishikawa","year":"2018","journal-title":"Oncotarget"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2016.11.045","article-title":"Identification of Novel Mutations in Japanese Ovarian Clear Cell Carcinoma Patients Using Optimized Targeted NGS for Clinical Diagnosis","volume":"144","author":"Maru","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bjc.2017.228","article-title":"Whole-Genome Sequencing Revealed Novel Prognostic Biomarkers and Promising Targets for Therapy of Ovarian Clear Cell Carcinoma","volume":"117","author":"Itamochi","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.humpath.2012.03.011","article-title":"Clinicopathologic and Biological Analysis of PIK3CA Mutation in Ovarian Clear Cell Carcinoma","volume":"43","author":"Rahman","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00109-016-1395-2","article-title":"Targeted Next-Generation Sequencing for Molecular Diagnosis of Endometriosis-Associated Ovarian Cancer","volume":"94","author":"Er","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.03.003","article-title":"Targeted Sequencing of a Specific Gene Panel Detects a High Frequency of ARID1A and PIK3CA Mutations in Ovarian Clear Cell Carcinoma","volume":"494","author":"Su","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ijc.34150","article-title":"Somatic Genomic Landscape of East Asian Epithelial Ovarian Carcinoma and Its Clinical Implications from Prospective Clinical Sequencing: A Korean Gynecologic Oncology Group Study (KGOG 3047)","volume":"151","author":"Sa","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neo.2020.06.002","article-title":"Genomic Characterization of Chinese Ovarian Clear Cell Carcinoma Identifies Driver Genes by Whole Exome Sequencing","volume":"22","author":"Yang","year":"2020","journal-title":"Neoplasia"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ng.3849","article-title":"Genomic Consequences of Aberrant DNA Repair Mechanisms Stratify Ovarian Cancer Histotypes","volume":"49","author":"Wang","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2017.12.005","article-title":"Genomic Landscape of Ovarian Clear Cell Carcinoma via Whole Exome Sequencing","volume":"148","author":"Kim","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Lapke, N., Chen, C.H., Chang, T.C., Chao, A., Lu, Y.J., Lai, C.H., Tan, K.T., Chen, H.C., Lu, H.Y., and Chen, S.J. (2021). Genetic Alterations and Their Therapeutic Implications in Epithelial Ovarian Cancer. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08233-5"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Oliveira, D.V.N.P., Schnack, T.H., Poulsen, T.S., Christiansen, A.P., H\u00f8gdall, C.K., and H\u00f8gdall, E.V. (2021). Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures. Cancers, 13.","DOI":"10.3390\/cancers13205242"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1158\/1078-0432.CCR-21-3817","article-title":"Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes","volume":"28","author":"Bolton","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/ijo.2012.1533","article-title":"Cytokine Gene Expression Signature in Ovarian Clear Cell Carcinoma","volume":"41","author":"Yanaihara","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1158\/0008-5472.CAN-05-3987","article-title":"Genetic Polymorphisms of Interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and Risk of Prostate Cancer","volume":"66","author":"Michaud","year":"2006","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-P\u00e9rez, C., Leung, J., Kay, C., Meehan, J., Gray, M., Dixon, J.M., and Turnbull, A.K. (2021). The Signal Transducer Il6st (Gp130) as a Predictive and Prognostic Biomarker in Breast Cancer. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070618"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 Signaling Pathway in Targeted Therapy for Cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molmed.2007.12.007","article-title":"The Wolf in Sheep\u2019s Clothing: The Role of Interleukin-6 in Immunity, Inflammation and Cancer","volume":"14","author":"Naugler","year":"2008","journal-title":"Trends Mol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.smim.2014.01.007","article-title":"The IL-6 Feed-Forward Loop: A Driver of Tumorigenesis","volume":"26","author":"Chang","year":"2014","journal-title":"Semin. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT Signaling Pathway: From Bench to Clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2017.04.025","article-title":"Crosstalk between STAT5 Activation and PI3K\/AKT Functions in Normal and Transformed Mammary Epithelial Cells","volume":"451","author":"Wehde","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/MTOR Pathway Signaling Occurs in Human CRLF2-Rearranged B-Precursor Acute Lymphoblastic Leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 Activation of MiR-21 and MiR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Hirata, Y., Murai, N., Yanaihara, N., Saito, M., Saito, M., Urashima, M., Murakami, Y., Matsufuji, S., and Okamoto, A. (2014). MicroRNA-21 Is a Candidate Driver Gene for 17q23-25 Amplification in Ovarian Clear Cell Carcinoma. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-799"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1078-0432.CCR-12-2726","article-title":"Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer","volume":"19","author":"Suryawanshi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_108","first-page":"142","article-title":"The Role of MicroRNAs in Endometriosis and Associated Reproductive Conditions","volume":"16","author":"Print","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/me.2009-0295","article-title":"A Link between Mir-100 and FRAP1\/MTOR in Clear Cell Ovarian Cancer","volume":"24","author":"Nagaraja","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO\u2013ESGO Consensus Conference Recommendations on Ovarian Cancer: Pathology and Molecular Biology, Early and Advanced Stages, Borderline Tumours and Recurrent Disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Shoji, T., Tatsuki, S., Abe, M., Tomabechi, H., Takatori, E., Kaido, Y., Nagasawa, T., Kagabu, M., Baba, T., and Itamochi, H. (2021). Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas. Cancers, 13.","DOI":"10.3390\/cancers13236120"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1158\/1078-0432.CCR-09-0365","article-title":"MTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary","volume":"15","author":"Mabuchi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3892\/or.2014.3268","article-title":"The PI3K\/MTOR Dual Inhibitor NVP-BEZ235 Reduces the Growth of Ovarian Clear Cell Carcinoma","volume":"32","author":"Oishi","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2019.07.004","article-title":"Low-Dose Triple Drug Combination Targeting the PI3K\/AKT\/MTOR Pathway and the MAPK Pathway Is an Effective Approach in Ovarian Clear Cell Carcinoma","volume":"461","author":"Caumanns","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.celrep.2018.10.096","article-title":"Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines","volume":"25","author":"Papp","year":"2018","journal-title":"Cell Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138920311795659443","article-title":"PP2A in the Regulation of Cell Motility and Invasion","volume":"12","author":"Basu","year":"2011","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2019.02.016","article-title":"Endometriosis-Associated Ovarian Cancer: What Have We Learned so Far?","volume":"493","author":"Chen","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.18632\/oncotarget.2092","article-title":"Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition","volume":"5","author":"Samartzis","year":"2014","journal-title":"Oncotarget"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13048-023-01160-y","article-title":"Treatment for Ovarian Clear Cell Carcinoma with Combined Inhibition of WEE1 and ATR","volume":"16","author":"Chien","year":"2023","journal-title":"J. Ovarian Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/1078-0432.CCR-15-2996","article-title":"Loss of ARID1A Activates ANXA1, Which Serves as a Predictive Biomarker for Trastuzumab Resistance","volume":"22","author":"Berns","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2022.10.006","article-title":"A Phase II Evaluation of Temsirolimus with Carboplatin and Paclitaxel Followed by Temsirolimus Consolidation in Clear Cell Ovarian Cancer: An NRG Oncology Trial","volume":"167","author":"Farley","year":"2022","journal-title":"Gynecol. Oncol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/8\/1253\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:34:51Z","timestamp":1760128491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/13\/8\/1253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":121,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["biom13081253"],"URL":"https:\/\/doi.org\/10.3390\/biom13081253","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]}}}